Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
30558
Beskrivning
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT01026610
Länk
https://clinicaltrials.gov/show/NCT01026610
Nyckelord
Versioner (2)
- 2018-06-14 2018-06-14 -
- 2021-09-27 2021-09-27 -
Rättsinnehavare
see clinical trials.gov
Uppladdad den
14 juni 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Hepatitis B NCT01026610
Eligibility Chronic Hepatitis B NCT01026610
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis B NCT01026610
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Gender; Age
Item
female or male, 18 to 65 years of age, inclusive
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Hepatitis B, Chronic
Item
chronic hepatitis b
boolean
C0524909 (UMLS CUI [1])
Therapeutic procedure, Virus Diseases Before Screening procedure
Item
not treated with anti-viral therapeutics including interferon or pegylated interferons for more than 12 weeks before screening
boolean
C0087111 (UMLS CUI [1,1])
C0042769 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0220908 (UMLS CUI [1,4])
C0042769 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0220908 (UMLS CUI [1,4])
Therapeutic procedure, Virus Diseases Before Screening procedure
Item
not treated with anti-viral therapeutics including interferon or pegylated interferons 6 months within screening
boolean
C0087111 (UMLS CUI [1,1])
C0042769 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0220908 (UMLS CUI [1,4])
C0042769 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0220908 (UMLS CUI [1,4])
Hepatitis B, Chronic, Compensated
Item
compensated chronic hepatitis b
boolean
C0524909 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0205432 (UMLS CUI [1,2])
Hepatitis B e antigen positive; Hepatitis B e antigen negative
Item
hbeag positive or hbeag negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
ALT (SGPT) level raised
Item
elevated serum alt level (1.2-10 x uln, inclusive)
boolean
C1443982 (UMLS CUI [1])
HCV coinfection; HDV confection; HIV coinfection
Item
co-infection with hepatitis c or d virus (hcv or hdv) or hiv
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Decompensated liver disease
Item
decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine clearance (calculated by cockroft-gault formula) less than 50 ml/min
boolean
C2711451 (UMLS CUI [1])
serum alpha-fetoprotein (AFP) measurement; Liver carcinoma, Ultrasonography
Item
screening alpha-fetoprotein (afp) value greater than or equal to 50 ng/ml, and a follow-up ultrasonography performed prior to baseline shows findings indicative of hcc
boolean
C0546833 (UMLS CUI [1])
C2239176 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
C2239176 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
Immunomodulation, Previous; Adrenal Cortex Hormones, Previous
Item
treatment with immunomodulatory agent or corticosteroids within 6 months prior to study entry.
boolean
C1963758 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0205156 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Pregnancy; Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Alcohol abuse; Illicit Drug abuse
Item
patient is currently abusing alcohol or illicit drugs
boolean
C0085762 (UMLS CUI [1])
C0086190 (UMLS CUI [2,1])
C0013146 (UMLS CUI [2,2])
C0086190 (UMLS CUI [2,1])
C0013146 (UMLS CUI [2,2])
Systemic disease, Clinical Significance
Item
significant systemic illnesses other than liver diseases
boolean
C0442893 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Liver diseases, Etiology aspects
Item
presence of other causes of liver disease
boolean
C0023895 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,2])
Organ Transplantation, Previous
Item
a history of organ transplantation
boolean
C0029216 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,2])
Anti-HBs antibody
Item
presence of anti-hbs at screening
boolean
C0948254 (UMLS CUI [1])